Hematology
First-of-Its-Kind Molecular Karyotyping Test Assists Hematologists in Diagnosing Leukemia
A new test kit can evaluate copy number aberrations (CNAs) in bone marrow cells and/or circulating cell-free DNA (cfDNA) via shallow whole-genome sequencing (sWGS), in combination with conventional cytogenetics technologies, to make leukemia diagnosis, molecular subtyping, prognostic stratification and treatment response monitoring more precise and comprehensive. More...11 Apr 2022
Blood Tests for Detecting Antioxidant and Inflammation Levels Could Diagnose Breast Cancer
Breast cancer is the most prevalent cancer in the world. Identifying new diagnostic techniques is of major importance to efforts that aim to minimize the disease’s devastating effects. Now, a new study that analyzes levels of antioxidants and stress markers in the blood could lead to a new diagnostic tool for breast cancer. More...07 Apr 2022
Blood Products Use in Trauma-Related Hemorrhagic Shock Patients Questioned
Treatment of hemorrhagic shock is now increasingly focused on the early use of hemorrhage control, tranexamic acid, and blood-based resuscitation with packed red cells and plasma. The improved survival from these and other strategies within streamlined trauma systems have been reported in the military and civilian settings, and have stimulated an interest in prehospital transfusion. More...05 Apr 2022
Deep Sequencing of CD34+ Cells Detects Measurable Residual Disease in AML
Monitoring of measurable residual disease (MRD) in patients with acute myeloid leukemia is predictive for disease recurrence and may identify patients who benefit from treatment intensification. Current MRD techniques rely on multicolor flow cytometry or molecular methods, but are limited in applicability or sensitivity. More...31 Mar 2022
Flow Cytometric Immunophenotyping Assessed for Classic Hodgkin Lymphoma
The diagnosis of classic Hodgkin lymphoma (CHL) requires morphologic and immunophenotypic identification of neoplastic Hodgkin and Reed-Sternberg cells (collectively referred to as HRS cells) intermixed with a background of reactive lymphocytes, histiocytes, plasma cells, and eosinophils. More...24 Mar 2022
First Non-Invasive Blood-Based Test Has Potential to Accurately Diagnose Alzheimer's Disease
Diadem srl (Milan, Italy) has presented data showing that its new AlzoSure Confirm blood test can accurately identify patients with Alzheimer's disease. AlzoSure Confirm has been developed on the same technology platform that underlies AlzoSure Predict, Diadem's prognostic blood test that can accurately predict whether or not an individual with early cognitive changes will progress to Alzheimer's disease up to six years before the condition is fully manifested. More...24 Mar 2022
Biomarker Panel for Risk of Early Respiratory Failure Following Hematopoietic Cell Transplantation
Allogeneic hematopoietic cell transplantation (HCT) is a life-saving therapy used for malignant and nonmalignant diseases. However, post-HCT pulmonary complications continue to be a significant problem. When severe, pulmonary complications can result in respiratory failure (RF), affecting 10% to 23% of patients. More...23 Mar 2022
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
.jpg)
New
Cortisol/Cortisone Saliva Controls
MassCheck Chromsystems Saliva Controls
New
Entamoeba One Step Card Test
CerTest Entamoeba
In Other News
Novel Blood Test Could Cut Hospital Stays for Children with Cancer
Personalized Blood Test Can Detect Persistent Lung Cancer
New Technique Improves Detection of Cancer DNA in Blood
Capillary and Venous Blood Sampling Compared for Coagulation Assays
Mindray Launches BC-700 Series Integrated CBC and ESR Hematology Analyzer for Small-to-Mid Sized Labs
New One-Stage Factor VIII Assay Evaluated
Unique Diagnostic Test Based on Mass Spectrometry Technique Accurately Identifies Early-Stage Alzheimer's Disease
ELISA Blood Test Uses Innovative Biomarker to Detect Heart Disease and Sudden Cardiac Arrest
Clinical Application of Leukocyte Counts Based on Targeted DNA Methylation Analysis
Nova Biomedical Launches CE-Marked Nova Max Pro Creatinine/eGFR Meter for Kidney Function Screening
Rapid POC Blood Ammonia Detector Could Dramatically Decrease Processing Times from Hours to Minutes
Blood Test Can Estimate Presence of Alzheimer’s Disease Changes and Blood Vessel Damage in the Brain
Algorithm Calculates Risk of Developing Prostate Cancer Using Results from Two Blood Markers
Molecular and Cytogenetic Characterization of Myelodysplastic Syndromes in Cell-Free DNA
Mitochondrial Damage May Explain the Increased Incidence of Hypertension in Black Adults
Simple Blood Test to Address Unmet Need in Alzheimer’s Disease Detection
Fujirebio Launches Neurodegeneration Assay for Automated Blood-Based Alzheimer’s Disease Biomarker Testing
First Approved Blood Test Predicts Likely Progression to Alzheimer's Up to Six Years in Advance
High-Risk Subtype of Relapsed Pediatric Acute Myeloid Leukemia Revealed
First-of-its-Kind Blood-Based Pan Cancer Early Detection Test Combines Protein Markers, Genomic and Epigenetic Features of Cancer in Blood
Coagulation Analyzers Evaluated and Compared in Coagulation Laboratory
Biomarker Panel for Risk of Early Respiratory Failure Following Hematopoietic Cell Transplantation
Micro-Mechanical Blood Clot Testing Using Smartphones
The Hematology channel at LabMedica covers the all aspect of plasma, coagulation, transfusion medicine, and blood banking, as well as related lab tools and techniques.